Status:
UNKNOWN
Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy
Lead Sponsor:
Hayandra Peduli Foundation
Collaborating Sponsors:
Koja Regional Public Hospital
Conditions:
Covid19
Sars-CoV-2 Infection
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
The positive cases of coronavirus disease-2019 (COVID-19) in Indonesia has been increasing rapidly since the first case found in March 2020 to date. Coronavirus 2 (SARS-CoV-2) virus disrupts human nor...
Detailed Description
PRP decreases IL-1β, IL-6, IL-8, and TNFα inflammatory genes expression while also reduces IL-1β and TNFα inflammatory cytokines production. PRP has also been showed to contain interleukin 1 receptor ...
Eligibility Criteria
Inclusion
- severe covid-19 patient in ICU
Exclusion
- CKD on hemodialysis, HIV positive, hepatitis, pregnant, destroyed lung, cancer
Key Trial Info
Start Date :
December 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 27 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04715360
Start Date
December 29 2020
End Date
December 27 2021
Last Update
January 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Koja Regional Public Hospital
Jakarta, DKI Jakarta, Indonesia, 14220